• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间自我报告的药剂师处方增加:使用理论领域框架识别处方的障碍和促进因素。

Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.

机构信息

Maritime SPOR SUPPORT Unit, Research, Innovation & Discovery Nova Scotia Health, 5790 University Ave., Halifax, Nova Scotia, B3H1V7, Canada.

Dalhousie University, Nova Scotia, B3H 4R2, Canada.

出版信息

Res Social Adm Pharm. 2023 Jan;19(1):133-143. doi: 10.1016/j.sapharm.2022.08.014. Epub 2022 Aug 20.

DOI:10.1016/j.sapharm.2022.08.014
PMID:36038458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9392557/
Abstract

BACKGROUND

Community pharmacists are positioned to improve access to medications through their ever-expanding role as prescribers, with this role becoming more pronounced during the COVID-19 pandemic.

OBJECTIVES

Our research aimed to determine the extent of self-reported pharmacist prescribing pre-COVID-19 and during the COVID-19 pandemic, to identify barriers and facilitators to pharmacist prescribing, and to explore the relationship between these factors and self-reported prescribing activity.

METHODS

A questionnaire based on the Theoretical Domains Framework (TDFv2) assessing self-reported prescribing was electronically distributed to all direct patient care pharmacists in NS (N = 1338) in July 2020. Wilcoxon signed-rank tests were used to examine temporal differences in self-reported prescribing activity. TDFv2 responses were descriptively reported as positive (agree/strongly agree), neutral (uncertain), and negative (strongly disagree/disagree) based on the 5-point Likert scale assessing barriers and facilitators to prescribing from March 2020 onward (i.e., 'during' COVID-19). Simple logistic regression was used to measure the relationship between TDFv2 domain responses and self-reported prescribing activity.

RESULTS

A total of 190 pharmacists (14.2%) completed the survey. Over 98% of respondents reported prescribing at least once per month in any of the approved prescribing categories, with renewals being the most common activity reported. Since the pandemic, activity in several categories of prescribing significantly increased, including diagnosis supported by protocol (29.0% vs. 58.9%, p < 0.01), minor and common ailments (25.3% vs 34.7%, p = 0.03), preventative medicine (22.1% vs. 33.2%, p < 0.01). Amongst the TDFv2 domains, Beliefs about Consequences domain had the largest influence on prescribing activity (OR = 3.13, 95% CI 1.41-6.97, p < 0.01), with Social Influences (OR = 2.85, 95% CI 1.42-5.70, p < 0.01) being the next most influential.

CONCLUSION

Self-reported prescribing by direct patient care community pharmacists in Nova Scotia increased during the COVID-19 pandemic, particularly for government-funded services. Key barriers to address, and facilitators to support pharmacist prescribing were identified and can be used to inform future interventions.

摘要

背景

社区药剂师的角色不断扩大,作为处方者,他们能够改善药物的获取途径,在 COVID-19 大流行期间,这种角色变得更加突出。

目的

我们的研究旨在确定在 COVID-19 大流行之前和期间,自我报告的药剂师处方的程度,确定处方的障碍和促进因素,并探讨这些因素与自我报告的处方活动之间的关系。

方法

基于理论领域框架(TDFv2)的问卷,评估自我报告的处方情况,于 2020 年 7 月以电子方式分发给新斯科舍省所有直接患者护理药剂师(N=1338)。使用 Wilcoxon 符号秩检验来检查自我报告的处方活动随时间的差异。基于 2020 年 3 月以来评估处方障碍和促进因素的 5 分李克特量表,将 TDFv2 回复描述为阳性(同意/强烈同意)、中性(不确定)和阴性(强烈不同意/不同意)。简单逻辑回归用于衡量 TDFv2 域响应与自我报告的处方活动之间的关系。

结果

共有 190 名药剂师(14.2%)完成了调查。超过 98%的受访者报告在任何批准的处方类别中每月至少开具一次处方,其中续方是最常见的报告活动。自大流行以来,几种处方类别的活动明显增加,包括协议支持的诊断(29.0%比 58.9%,p<0.01)、轻微和常见疾病(25.3%比 34.7%,p=0.03)、预防医学(22.1%比 33.2%,p<0.01)。在 TDFv2 领域中,信念对后果领域对处方活动的影响最大(OR=3.13,95%CI 1.41-6.97,p<0.01),社会影响(OR=2.85,95%CI 1.42-5.70,p<0.01)是下一个最有影响力的因素。

结论

新斯科舍省直接患者护理社区药剂师的自我报告处方在 COVID-19 大流行期间有所增加,特别是对于政府资助的服务。确定了处方的关键障碍和促进因素,可以为未来的干预措施提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/a93ec1d25a64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/8ca9e6ad570e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/143dff613e0c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/a93ec1d25a64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/8ca9e6ad570e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/143dff613e0c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4470/9392557/a93ec1d25a64/gr3_lrg.jpg

相似文献

1
Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.在 COVID-19 大流行期间自我报告的药剂师处方增加:使用理论领域框架识别处方的障碍和促进因素。
Res Social Adm Pharm. 2023 Jan;19(1):133-143. doi: 10.1016/j.sapharm.2022.08.014. Epub 2022 Aug 20.
2
Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework.使用理论领域框架识别药剂师处方的障碍和促进因素与自我报告的处方活动之间的关系。
Res Social Adm Pharm. 2018 Aug;14(8):784-791. doi: 10.1016/j.sapharm.2017.10.004. Epub 2017 Oct 24.
3
Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.药剂师开处方:尼日利亚药剂师观点的横断面调查
Int J Pharm Pract. 2018 Apr;26(2):111-119. doi: 10.1111/ijpp.12381. Epub 2017 May 12.
4
Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position.重症监护中药师独立处方:一项关于确定2014年英国现状的全国性问卷调查结果
Int J Pharm Pract. 2016 Apr;24(2):104-13. doi: 10.1111/ijpp.12219. Epub 2015 Sep 30.
5
Community pharmacists' expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study.社区药剂师在 COVID-19 前后支持患者方面不断扩大的角色:一项探索性定性研究。
Int J Clin Pharm. 2023 Feb;45(1):64-78. doi: 10.1007/s11096-022-01430-7. Epub 2022 Oct 26.
6
Assessment of the implementation of pharmacist prescribing: Challenges and pathways for ambulatory practice.药师处方实施情况评估:门诊实践的挑战与途径
Res Social Adm Pharm. 2024 Sep;20(9):870-879. doi: 10.1016/j.sapharm.2024.05.002. Epub 2024 May 11.
7
Pharmacist prescribing in Northern Ireland: a quantitative assessment.北爱尔兰的药剂师处方:定量评估。
Int J Clin Pharm. 2011 Oct;33(5):824-31. doi: 10.1007/s11096-011-9545-7. Epub 2011 Aug 10.
8
Community pharmacists' roles during the closure stage of the COVID-19 pandemic in Newfoundland and Labrador, Canada: a qualitative case study.加拿大纽芬兰和拉布拉多省 COVID-19 大流行关闭阶段的社区药剂师角色:定性案例研究。
BMJ Open. 2024 Aug 5;14(8):e085338. doi: 10.1136/bmjopen-2024-085338.
9
A theoretically informed, mixed-methods study of pharmacists' aspirations and readiness to implement pharmacist prescribing.一项基于理论的、混合方法研究,探讨药剂师的愿望和准备情况,以实施药剂师处方。
Int J Clin Pharm. 2021 Dec;43(6):1638-1650. doi: 10.1007/s11096-021-01296-1. Epub 2021 Jun 14.
10
Improving appropriate polypharmacy for older people in primary care: selecting components of an evidence-based intervention to target prescribing and dispensing.改善基层医疗中老年人的合理联合用药:选择基于证据的干预措施组成部分以针对处方开具和配药环节
Implement Sci. 2015 Nov 16;10:161. doi: 10.1186/s13012-015-0349-3.

引用本文的文献

1
Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory.实现药剂师开处方:在新斯科舍省运用行为改变理论所汲取的经验教训。
Can Pharm J (Ott). 2024 Nov 11;158(1):29-40. doi: 10.1177/17151635241280724. eCollection 2025 Jan-Feb.
2
Patient perspectives on the vital primary care role of community pharmacists in Nova Scotia, Canada: qualitative findings from the PUPPY Study.患者视角下加拿大新斯科舍省社区药剂师基本医疗关键作用:PUPPY 研究的定性发现。
Int J Pharm Pract. 2024 May 7;32(3):216-222. doi: 10.1093/ijpp/riae008.
3
Community pharmacists' perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains framework.

本文引用的文献

1
Exploring pharmacists' resilience, coping and burnout during the COVID-19 pandemic.探索药剂师在新冠疫情期间的适应力、应对方式和职业倦怠。
Explor Res Clin Soc Pharm. 2022 Mar;5:100104. doi: 10.1016/j.rcsop.2022.100104. Epub 2022 Jan 15.
2
Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.新冠疫情期间应急响应中的药学实践:来自澳大利亚的经验教训
Res Social Adm Pharm. 2022 Aug;18(8):3453-3462. doi: 10.1016/j.sapharm.2021.08.013. Epub 2021 Aug 30.
3
Impact of COVID-19 on frontline pharmacists' roles and services in Canada: The INSPIRE Survey.
社区药剂师对晚期慢性肾病患者肾功能评估及药物剂量调整的看法:一项运用理论域框架的定性研究
Can Pharm J (Ott). 2023 Jul 7;156(5):272-281. doi: 10.1177/17151635231176530. eCollection 2023 Sep-Oct.
2019冠状病毒病对加拿大一线药剂师角色及服务的影响:INSPIRE调查
Can Pharm J (Ott). 2021 Jul 9;154(6):368-373. doi: 10.1177/17151635211028253. eCollection 2021 Nov-Dec.
4
Identifying barriers, facilitators and behaviour change techniques to the adoption of the full scope of pharmacy practice among pharmacy professionals: Using the Theoretical Domains Framework.识别药学专业人员在采用全面药学实践过程中的障碍、促进因素和行为改变技术:运用理论领域框架
Res Social Adm Pharm. 2021 Aug;17(8):1396-1406. doi: 10.1016/j.sapharm.2020.10.003. Epub 2020 Oct 20.
5
COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic.新冠疫情是职业角色认同演变的催化剂?对全球药剂师应对新冠疫情的角色与服务的范围综述
Pharmacy (Basel). 2021 May 4;9(2):99. doi: 10.3390/pharmacy9020099.
6
How pharmacists perceive their professional identity: a scoping review and discursive analysis.药剂师如何看待自己的职业身份:范围综述和话语分析。
Int J Pharm Pract. 2021 Aug 11;29(4):299-307. doi: 10.1093/ijpp/riab020.
7
Burnout and the challenges facing pharmacists during COVID-19: results of a national survey.职业倦怠与药剂师在新冠疫情期间面临的挑战:一项全国性调查结果
Int J Clin Pharm. 2021 Jun;43(3):716-725. doi: 10.1007/s11096-021-01268-5. Epub 2021 Apr 13.
8
Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis.加拿大安大略省药剂师治疗小病的经济评价:成本最小化分析。
Int J Pharm Pract. 2021 May 25;29(3):228-234. doi: 10.1093/ijpp/riab006.
9
Pharmacy response to COVID-19: lessons learnt from Canada.药房对COVID-19的应对:加拿大的经验教训。
J Pharm Policy Pract. 2020 Dec 9;13(1):76. doi: 10.1186/s40545-020-00280-w.
10
Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic.加拿大药剂师在新冠疫情期间应对药品短缺问题中的作用。
Can Pharm J (Ott). 2020 May 29;153(4):198-203. doi: 10.1177/1715163520929387. eCollection 2020 Jul-Aug.